155 related articles for article (PubMed ID: 3486824)
1. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
[TBL] [Abstract][Full Text] [Related]
2. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Yan XJ; Kohno M; Yoshioka M; Fujikawa H; Igarashi H; Okubo M; Awano F; Saito-Taki T
Clin Exp Immunol; 1987 Jun; 68(3):638-47. PubMed ID: 3498581
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
4. Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
Uchiyama T; Kamagata Y; Yan XJ; Kawachi A; Fujikawa H; Igarashi H; Okubo M
Clin Exp Immunol; 1989 Feb; 75(2):239-44. PubMed ID: 2784735
[TBL] [Abstract][Full Text] [Related]
5. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
6. Induction of murine hemopoietic growth factors by toxic shock syndrome toxin-1.
Galelli A; Anderson S; Charlot B; Alouf JE
J Immunol; 1989 Apr; 142(8):2855-63. PubMed ID: 2784816
[TBL] [Abstract][Full Text] [Related]
7. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells.
Chatila T; Wood N; Parsonnet J; Geha RS
J Immunol; 1988 Feb; 140(4):1250-5. PubMed ID: 2830336
[TBL] [Abstract][Full Text] [Related]
8. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
[TBL] [Abstract][Full Text] [Related]
9. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin.
Uchiyama T; Kamagata Y; Wakai M; Yoshioka M; Fujikawa H; Igarashi H
Microbiol Immunol; 1986; 30(5):469-83. PubMed ID: 3489157
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
11. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
12. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin enhancement of toxic shock syndrome toxin 1-induced secretion of interleukin 1 by murine macrophages.
Beezhold DH; Best GK; Bonventre PF; Thompson M
Rev Infect Dis; 1989; 11 Suppl 1():S289-93. PubMed ID: 2784586
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
Miethke T; Wahl C; Heeg K; Wagner H
J Immunol; 1993 May; 150(9):3776-84. PubMed ID: 8473732
[TBL] [Abstract][Full Text] [Related]
15. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis.
Lester MR; Hofer MF; Gately M; Trumble A; Leung DY
J Immunol; 1995 Jun; 154(11):6174-81. PubMed ID: 7751657
[TBL] [Abstract][Full Text] [Related]
16. Toxic shock syndrome--the role of the toxin.
Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
[TBL] [Abstract][Full Text] [Related]
17. Patterns of interferon-gamma mRNA expression in toxic shock syndrome toxin-1 expanded V beta 11+ T lymphocytes.
Zhao YX; Abdelnour A; Ljungdahl A; Olsson T; Tarkowski A
Cell Immunol; 1995 Mar; 161(1):28-33. PubMed ID: 7867082
[TBL] [Abstract][Full Text] [Related]
18. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen.
Takahashi N; Imanishi K; Nishida H; Uchiyama T
J Immunol; 1995 Dec; 155(11):5213-9. PubMed ID: 7594532
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
20. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
